CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation.
about
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease.Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice.Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
P2860
CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD40 Generation 2.5 Antisense ...... pathy and Kidney Inflammation.
@en
type
label
CD40 Generation 2.5 Antisense ...... pathy and Kidney Inflammation.
@en
prefLabel
CD40 Generation 2.5 Antisense ...... pathy and Kidney Inflammation.
@en
P2093
P2860
P356
P1476
CD40 Generation 2.5 Antisense ...... opathy and Kidney Inflammation
@en
P2093
Aaron J Donner
Mark J Graham
Rosanne M Crooke
Steve T Yeh
P2860
P356
10.1038/MTNA.2015.40
P577
2015-12-01T00:00:00Z